This PRA Insights report focusing on Alzheimer’s disease research was compiled from survey data gathered at the 2017 Alzheimer’s Association International Conference (AAIC). The aim of the survey was to gather insight on clinical development and the future of research in Alzheimer’s disease from pharma and biotech, academic researchers, next generation investigators, clinicians and the care research community involved in the prevention and treatment of Alzheimer’s disease and other dementias.
Explore related content and topics
Blog
A Caregiver’s Experience with Glioblastoma
Glioblastoma (GBM) is one of the most complex, deadly, treatment-resistant cancers that accounts for 48% of all primary malignant brain tumors. In…
Capability
Pain Studies at PRA Early Development Services
PRA Health Sciences offers a range of pain models to assess pain perception and the efficacy of experimental analgesics in healthy volunteers and…
Newsletter
Industry Watch
In the first week of December, Industry Watch brings our readers news of promising developments in oncology. There’s a machine learning method being…